BRIEF published on 11/23/2024 at 10:59, 1 year 11 months ago TME Pharma Presents Findings on NOX-A12 in Glioblastoma Cancer Therapy Glioblastoma NOX-A12 Immune Checkpoint Inhibition Tumor Microenvironment
PRESS RELEASE published on 11/23/2024 at 10:54, 1 year 11 months ago Informations privilégiées / Autres communiqués TME Pharma annonce la présentation d'un poster par le National Cancer Institute américain sur l'inhibition de CXCL12 par NOX-A12 dans le glioblastome à la réunion annuelle du SNO 2024 Glioblastome TME Pharma NOX-A12 National Cancer Institute Inhibition
PRESS RELEASE published on 11/23/2024 at 10:54, 1 year 11 months ago Inside Information / Other news releases TME Pharma presents poster on NOX-A12 inhibition of CXCL12 in glioblastoma at 2024 SNO Annual Meeting, demonstrating enhanced anti-tumor immune responses in brain cancer models Glioblastoma TME Pharma NOX-A12 CXCL12 Inhibition SNO Annual Meeting
BRIEF published on 08/12/2024 at 19:05, 2 years 2 months ago TME Pharma augmente les ressources allouées au contrat de liquidité Contrat De Liquidité Répartition Des Actions Décision De L'AMF TME Pharma Investir Dans Des Titres
BRIEF published on 08/12/2024 at 19:05, 2 years 2 months ago TME Pharma Increases Allocated Resources for Liquidity Contract Liquidity Contract INVEST SECURITIES AMF Decision TME Pharma Share Allocation
PRESS RELEASE published on 08/12/2024 at 19:00, 2 years 2 months ago Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité TME Pharma augmente les ressources allouées au contrat de liquidité avec Invest Securities pour soutenir trésorerie et titres. Détails disponibles post-augmentation Contrat Liquidité INVEST SECURITIES Ressources TME Pharma
PRESS RELEASE published on 08/12/2024 at 19:00, 2 years 2 months ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract TME Pharma increases resources for liquidity contract with Invest Securities to support cash balance and securities. Details of the update provided in accordance with AMF regulations Liquidity Contract Biotechnology INVEST SECURITIES AMF Regulations TME Pharma
Published on 10/28/2026 at 08:00, 44 minutes ago Algo Grande Copper Makes New Skarn Discovery at Adelita; Step-Out Hole AG-CG-PH2-003 Returns a Combined 139.81 Metres of 1.3% CuEq from Cerro Grande and the New Margarita Skarn
Published on 10/28/2026 at 02:55, 5 hours 49 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 5 hours 54 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 9 hours 4 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 9 hours 19 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/28/2026 at 08:05, 39 minutes ago CookieYes Earns Built for Shopify Badge for Its Cookie Consent App
Published on 10/28/2026 at 08:00, 44 minutes ago Coinsilium Group Limited: Portfolio Ventures: Strategic and Commercial Update
Published on 10/28/2026 at 08:00, 44 minutes ago TRATON GROUP increases unit sales, sales revenue, and adjusted operating result in the first nine months of 2026
Published on 10/28/2026 at 08:00, 44 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 44 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 14 hours 44 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 14 hours 44 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026